Treatment of acute non lymphocytic leukemia. Results of a prospective trial of daunorubicin, arabinosylcytosine and 6-thioguanine (DAT) versus DAT plus vindesine and etoposide.

Giuseppe Bandini, L Mangoni, Giovanna Cavazzini et al.|PubMed|1988

Cited by 11